AAAAAA

   
Results: 1-13 |
Results: 13
EFFECTIVE TREATMENT OF EARLY ENDOBRONCHIAL CANCER WITH REGIONAL ADMINISTRATION OF LIPOSOME-P53 COMPLEXES
Authors: ZOU YY ZONG G LING YH HAO MM LOZANO G HONG WK PEREZSOLER R
Citation: Yy. Zou et al., EFFECTIVE TREATMENT OF EARLY ENDOBRONCHIAL CANCER WITH REGIONAL ADMINISTRATION OF LIPOSOME-P53 COMPLEXES, Journal of the National Cancer Institute, 90(15), 1998, pp. 1130-1137
SEROPREVALENCE OF HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH HEPATITIS-B
Authors: FAN XG ZOU YY WU AH LI TG HU GL ZHANG Z
Citation: Xg. Fan et al., SEROPREVALENCE OF HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH HEPATITIS-B, British journal of biomedical science, 55(3), 1998, pp. 176-178
ANNAMYCIN CIRCUMVENTS RESISTANCE MEDIATED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) IN BREAST MCF-7 AND SMALL-CELL LUNG UMCC-1 CANCER CELL-LINES SELECTED FOR RESISTANCE TO ETOPOSIDE
Authors: PEREZSOLER R NEAMATI N ZOU YY SCHNEIDER E DOYLE LA ANDREEFF M PRIEBE W LING YH
Citation: R. Perezsoler et al., ANNAMYCIN CIRCUMVENTS RESISTANCE MEDIATED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) IN BREAST MCF-7 AND SMALL-CELL LUNG UMCC-1 CANCER CELL-LINES SELECTED FOR RESISTANCE TO ETOPOSIDE, International journal of cancer, 71(1), 1997, pp. 35-41
LYOPHILIZED PRELIPOSOMAL FORMULATION OF THE NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN - EFFECT OF SURFACTANT ON LIPOSOME FORMATION, STABILITY AND SIZE
Authors: ZOU YY PRIEBE W PEREZSOLER R
Citation: Yy. Zou et al., LYOPHILIZED PRELIPOSOMAL FORMULATION OF THE NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN - EFFECT OF SURFACTANT ON LIPOSOME FORMATION, STABILITY AND SIZE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 103-108
LIPID COMPLEXED CAMPTOTHECIN - FORMULATION AND INITIAL BIODISTRIBUTION AND ANTITUMOR-ACTIVITY STUDIES
Authors: SUGARMAN SM ZOU YY WASAN K POIROT K KUMI R REDDY S PEREZSOLER R
Citation: Sm. Sugarman et al., LIPID COMPLEXED CAMPTOTHECIN - FORMULATION AND INITIAL BIODISTRIBUTION AND ANTITUMOR-ACTIVITY STUDIES, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 531-538
PRECLINICAL TOXICITY OF LIPOSOME-INCORPORATED ANNAMYCIN - SELECTIVE BONE-MARROW TOXICITY WITH LACK OF CARDIOTOXICITY
Authors: ZOU YY PRIEBE W STEPHENS LC PEREZSOLER R
Citation: Yy. Zou et al., PRECLINICAL TOXICITY OF LIPOSOME-INCORPORATED ANNAMYCIN - SELECTIVE BONE-MARROW TOXICITY WITH LACK OF CARDIOTOXICITY, Clinical cancer research, 1(11), 1995, pp. 1369-1374
EFFECT OF VESICLE SIZE AND LIPID-COMPOSITION ON THE IN-VIVO TUMOR SELECTIVITY AND TOXICITY OF THE NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN INCORPORATED IN LIPOSOMES
Authors: ZOU YY LING YH REDDY S PRIEBE W PEREZSOLER R
Citation: Yy. Zou et al., EFFECT OF VESICLE SIZE AND LIPID-COMPOSITION ON THE IN-VIVO TUMOR SELECTIVITY AND TOXICITY OF THE NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN INCORPORATED IN LIPOSOMES, International journal of cancer, 61(5), 1995, pp. 666-671
PARTIAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE BY ANNAMYCIN IS ASSOCIATED WITH COMPARABLE INHIBITION OF DNA-SYNTHESIS IN THE NUCLEAR MATRIX OF SENSITIVE AND RESISTANT CELLS
Authors: LING YH ZOU YY PRIEBE W PEREZSOLER R
Citation: Yh. Ling et al., PARTIAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE BY ANNAMYCIN IS ASSOCIATED WITH COMPARABLE INHIBITION OF DNA-SYNTHESIS IN THE NUCLEAR MATRIX OF SENSITIVE AND RESISTANT CELLS, International journal of cancer, 61(3), 1995, pp. 402-408
CELLULAR PHARMACOLOGY OF THE PARTIALLY NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN ENTRAPPED IN LIPOSOMES IN KB AND KB-V1 CELLS
Authors: PEREZSOLER R LING YH ZOU YY PRIEBE W
Citation: R. Perezsoler et al., CELLULAR PHARMACOLOGY OF THE PARTIALLY NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN ENTRAPPED IN LIPOSOMES IN KB AND KB-V1 CELLS, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 109-118
ANTITUMOR-ACTIVITY OF FREE AND LIPOSOME-ENTRAPPED ANNAMYCIN, A LIPOPHILIC ANTHRACYCLINE ANTIBIOTIC WITH NON-CROSS-RESISTANCE PROPERTIES
Authors: ZOU YY LING YH VAN NT PRIEBE W PEREZSOLER R
Citation: Yy. Zou et al., ANTITUMOR-ACTIVITY OF FREE AND LIPOSOME-ENTRAPPED ANNAMYCIN, A LIPOPHILIC ANTHRACYCLINE ANTIBIOTIC WITH NON-CROSS-RESISTANCE PROPERTIES, Cancer research, 54(6), 1994, pp. 1479-1484
ORGAN DISTRIBUTION AND TUMOR UPTAKE OF ANNAMYCIN, A NEW ANTHRACYCLINEDERIVATIVE WITH HIGH-AFFINITY FOR LIPID-MEMBRANES, ENTRAPPED IN MULTILAMELLAR VESICLES
Authors: ZOU YY PRIEBE W LING YH PEREZSOLER R
Citation: Yy. Zou et al., ORGAN DISTRIBUTION AND TUMOR UPTAKE OF ANNAMYCIN, A NEW ANTHRACYCLINEDERIVATIVE WITH HIGH-AFFINITY FOR LIPID-MEMBRANES, ENTRAPPED IN MULTILAMELLAR VESICLES, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 190-196
QUANTITATIVE-ANALYSIS OF THE LIPOPHILIC DOXORUBICIN ANALOG ANNAMYCIN IN PLASMA AND TISSUE SAMPLES BY REVERSED-PHASE CHROMATOGRAPHY
Authors: ZOU YY HAYMAN A PRIEBE W PEREZSOLER R
Citation: Yy. Zou et al., QUANTITATIVE-ANALYSIS OF THE LIPOPHILIC DOXORUBICIN ANALOG ANNAMYCIN IN PLASMA AND TISSUE SAMPLES BY REVERSED-PHASE CHROMATOGRAPHY, Journal of pharmaceutical sciences, 82(11), 1993, pp. 1151-1154
ENHANCED THERAPEUTIC EFFECT AGAINST LIVER-W256 CARCINOSARCOMA WITH TEMPERATURE-SENSITIVE LIPOSOMAL ADRIAMYCIN ADMINISTERED INTO THE HEPATIC-ARTERY
Authors: ZOU YY YAMAGISHI M HORIKOSHI I UENO M GU XQ PEREZSOLER R
Citation: Yy. Zou et al., ENHANCED THERAPEUTIC EFFECT AGAINST LIVER-W256 CARCINOSARCOMA WITH TEMPERATURE-SENSITIVE LIPOSOMAL ADRIAMYCIN ADMINISTERED INTO THE HEPATIC-ARTERY, Cancer research, 53(13), 1993, pp. 3046-3051
Risultati: 1-13 |